Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07186556
- Status
- Recruiting
Conditions
- Brain Tumor Adult
- Cancer
- Fatigue
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 39 Years
- Healthy Volunteers
- Not accepted
Interventions
- Survivorship Education — BEHAVIORALParticipants will participate in discussions with a trainer via videoconference of any adverse events, resolving technical issues related to the activity tracker, and discussing survivorship topics using the NCI's Facing Forward Life After Cancer Treatment booklet. Participants will receive calls twice weekly during weeks 1-6 and once weekly during weeks 7-12
- RISE-YA Intervention — BEHAVIORALParticipants will receive one-on-one energy conservation (EC) counseling, behavior coaching, and individualized, progressive strength and aerobic training exercises with a trainer via videoconference. Participants will receive calls twice weekly during weeks 1-6 and once weekly during weeks 7-12. Each call will last one hour. Participants will also receive prescriptions for self-led exercise sessions.
Study Details
The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer survivors.
Key Dates
- First listed
- Sep 22, 2025
- Start date
- Sep 9, 2025
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 75 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Participant Group/ArmParticipants will randomized at baseline stratifying by gender and CRF level
- Experimental: Intervention GroupParticipants will randomized at baseline stratifying by gender and CRF level
Primary Outcome Measure
Cancer Related Fatigue [ Time Frame: Measured at T1 (baseline), T2 (12 weeks), and T3 (24 weeks) ]
Central Contacts
- Michael Roth, MD(713) 792-7751
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | Michael Roth, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Long-Term Follow-Up of Recipient of Gene Transfer ResearchRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Caris Biorepository Research ProtocolRecruiting · Caris Science, Inc. · Mobile, Alabama
- Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-upRecruiting · Center for Biomedical Research, LLC · Jacksonville, Florida